{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:14:02Z","timestamp":1780071242771,"version":"3.54.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pmr.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T19:10:24Z","timestamp":1527880224000},"page":"483-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Muscle Overactivity in the Upper Motor Neuron Syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"Anne Felicia","family":"Ambrose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Dohle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmr.2018.03.004_bib1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/0140-6736(90)90389-M","article-title":"What is spasticity?","volume":"335","author":"Lance","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.pmr.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/practneurol-2011-000155","article-title":"Spasticity: pathophysiology, evaluation and management","volume":"12","author":"Kheder","year":"2012","journal-title":"Pract Neurol"},{"key":"10.1016\/j.pmr.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000091222","article-title":"Spasticity and its association with functioning and health-related quality of life 18\u00a0months after stroke","volume":"21","author":"Welmer","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.pmr.2018.03.004_bib4","first-page":"193","article-title":"Spasticity: revisiting the role and the individual value of several pharmacological treatments","volume":"27","author":"Lapeyre","year":"2010","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.pmr.2018.03.004_bib5","series-title":"Stroke: national clinical guideline for diagnosis and initial management of acute stroke and transient ischaemic attack (TIA)","author":"National Collaborating Centre for Chronic Conditions (UK)","year":"2008"},{"key":"10.1016\/j.pmr.2018.03.004_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1542\/peds.111.1.e89","article-title":"Classification and definitions of disorders caused by hypertonia in childhood","volume":"111","author":"Sanger","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.pmr.2018.03.004_bib7","unstructured":"Available at: http:\/\/www.neurorehabresource.org\/Files\/NRR_Differential_Diagnosis.pdf. Accessed October 21, 2017."},{"key":"10.1016\/j.pmr.2018.03.004_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modifilied Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys Ther"},{"key":"10.1016\/j.pmr.2018.03.004_bib9","first-page":"S23","article-title":"Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy","volume":"6","author":"Boyd","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pmr.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF01530764","article-title":"Goal attainment scaling: a general method of evaluating comprehensive mental health programmes","volume":"4","author":"Kiresuk","year":"1968","journal-title":"Community Ment Health J"},{"issue":"9","key":"10.1016\/j.pmr.2018.03.004_bib11","first-page":"530","article-title":"Neurological rehabilitation and the management of spasticity","volume":"44","author":"Stevenson","year":"2016","journal-title":"Neurol Rehabil"},{"issue":"1","key":"10.1016\/j.pmr.2018.03.004_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1545968309343213","article-title":"Management of spasticity after spinal cord injury: current techniques and future directions","volume":"24","author":"Elbasiouny","year":"2010","journal-title":"Neurorehabil Neural Repair"},{"issue":"11","key":"10.1016\/j.pmr.2018.03.004_bib13","first-page":"1173","article-title":"Rehabilitation medicine: 3. Management of adult spasticity","volume":"169","author":"Satkunam","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.pmr.2018.03.004_bib14","unstructured":"National Institute for Health and Care Excellence. Spasticity in Under 19s: Management. Clinical Guideline. 2012. Available at: http:\/\/www.nice.org.uk\/guidance\/cg145. Accessed October 20, 2017."},{"issue":"3","key":"10.1016\/j.pmr.2018.03.004_bib15","first-page":"145","article-title":"Chapter 13: the diagnosis and management of adults with spasticity","volume":"110","author":"Balakrishnan","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.pmr.2018.03.004_bib16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1136\/jnnp.2003.025551","article-title":"Does reducing spasticity translate into functional benefit? An exploratory meta-analysis","volume":"75","author":"Francis","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pmr.2018.03.004_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jocn.2017.02.044","article-title":"Breakthroughs in the spasticity management: are non-pharmacological treatments the future?","volume":"39","author":"Naro","year":"2017","journal-title":"J\u00a0Clin Neurosci"},{"issue":"11","key":"10.1016\/j.pmr.2018.03.004_bib18","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1177\/1352458516643600","article-title":"Pharmacological management of spasticity in multiple sclerosis: systematic review and consensus paper","volume":"22","author":"Otero-Romero","year":"2016","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.004_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","article-title":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review","volume":"28","author":"Chou","year":"2004","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.004_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/088307389601100202","article-title":"Baclofen in the treatment of cerebral palsy","volume":"11","author":"Albright","year":"1996","journal-title":"J\u00a0Child Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.004_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00001199-200403000-00003","article-title":"Orally delivered baclofen to control spastic hypertonia in acquired brain injury","volume":"19","author":"Meythaler","year":"2004","journal-title":"J\u00a0Head Trauma Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1212\/WNL.26.5.441","article-title":"An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions","volume":"26","author":"Duncan","year":"1976","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.pmr.2018.03.004_bib23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1080\/09638280701602392","article-title":"Pregabalin in the treatment of spasticity: a retrospective case series","volume":"30","author":"Bradley","year":"2008","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0003-9993(00)90135-7","article-title":"Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial","volume":"81","author":"Cutter","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.004_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1185\/030079908X261113","article-title":"A\u00a0practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury","volume":"24","author":"Kamen","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.pmr.2018.03.004_bib26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1185\/03007998909110141","article-title":"A\u00a0double-blind, long-term study of tizanidine (\u2018sirdalud\u2019) in spasticity due to cerebrovascular lesions","volume":"11","author":"Medici","year":"1989","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pmr.2018.03.004_bib27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.apmr.2011.04.012","article-title":"Safety of low-dose oral dantrolene sodium on hepatic function","volume":"92","author":"Kim","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jnnp.39.4.350","article-title":"Comparison of dantrolene sodium and diazepam in the treatment of spasticity","volume":"39","author":"Schmidt","year":"1976","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.pmr.2018.03.004_bib29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.1975.03240200058032","article-title":"Evaluation of a muscle relaxant: dantrolene sodium (dantrium)","volume":"231","author":"Dykes","year":"1975","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pmr.2018.03.004_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1185\/03007998409109576","article-title":"Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function","volume":"9","author":"Ketel","year":"1984","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pmr.2018.03.004_bib31","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/hs0901.095682","article-title":"Intrathecal baclofen for spastic hypertonia from stroke","volume":"32","author":"Meythaler","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.pmr.2018.03.004_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0003-9993(99)90301-5","article-title":"Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience","volume":"80","author":"Meythaler","year":"1999","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2340\/16501977-2211","article-title":"Efficacy and safety of oral baclofen in the management of spasticity: a rationale for intrathecal baclofen","volume":"49","author":"Ertzgaard","year":"2017","journal-title":"J\u00a0Rehabil Med"},{"key":"10.1016\/j.pmr.2018.03.004_bib34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ner.12447","article-title":"Best practices for intrathecal baclofen therapy: patient selection","volume":"19","author":"Saulino","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1016\/j.pmr.2018.03.004_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/apmr.2002.32820","article-title":"Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome","volume":"83","author":"Coffey","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"10.1016\/j.pmr.2018.03.004_bib36","first-page":"158","article-title":"Intrathecal baclofen after traumatic brain injury: early treatment using a new technique to prevent spasticity","volume":"50","author":"Francois","year":"2001","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.pmr.2018.03.004_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pmrj.2014.09.021","article-title":"Botulinum toxin injection techniques for the management of adult spasticity","volume":"7","author":"Walker","year":"2015","journal-title":"PM R"},{"key":"10.1016\/j.pmr.2018.03.004_bib38","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.jbiomech.2013.07.028","article-title":"Do skeletal muscle properties recover following repeat onabotulinum toxin A injections?","volume":"46","author":"Fortuna","year":"2013","journal-title":"J\u00a0Biomech"},{"key":"10.1016\/j.pmr.2018.03.004_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib40","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"De Paiva","year":"1999","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.pmr.2018.03.004_bib41","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/WNL.43.9.1715","article-title":"Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance","volume":"43","author":"Zuber","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2018.03.004_bib42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp.68.6.707","article-title":"Botulinum toxin (dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study","volume":"68","author":"Hyman","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pmr.2018.03.004_bib43","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A\u00a0randomized, double-blind, palcebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (dysport) with placebo in upper limb spasticity after stroke","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pmr.2018.03.004_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.61.1.30","article-title":"Use of botulinum toxin in stroke patients with severe upper limb spasticity","volume":"61","author":"Bhakta","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.pmr.2018.03.004_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stoke","volume":"347","author":"Brashear","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pmr.2018.03.004_bib46","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/STROKEAHA.108.544346","article-title":"Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients","volume":"40","author":"Caty","year":"2009","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.pmr.2018.03.004_bib47","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00002060-199811000-00012","article-title":"Comparison of phenol block and botulinum toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial","volume":"77","author":"Kirazli","year":"1998","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib48","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1053\/apmr.2000.9395","article-title":"Alcohol neurolysis of the spastic nerve in the treatment of hemiplegic knee flexor spastcity: clinical outcomes","volume":"81","author":"Chau","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"issue":"13","key":"10.1016\/j.pmr.2018.03.004_bib49","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jama.1967.03120260051008","article-title":"Peripheral nerve block with phenol in the management of spasticity","volume":"200","author":"Khalili","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.pmr.2018.03.004_bib50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000016747","article-title":"Muscle spindle reinnervation following phenol block","volume":"166","author":"Wolf","year":"2000","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.pmr.2018.03.004_bib51","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.apmr.2008.02.015","article-title":"The effects of stretching in spasticity: a systematic review","volume":"89","author":"Bovend\u2019Eerdt","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"10.1016\/j.pmr.2018.03.004_bib52","article-title":"Stretch for the treatment and prevention of contractures","author":"Harvey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pmr.2018.03.004_bib53","first-page":"231","article-title":"Electrical stimulation and splinting were not clearly more effective than splinting alone for contracture management after acquired brain injury: a randomised trial","volume":"58","author":"Leung","year":"2012","journal-title":"J\u00a0Physiother"},{"issue":"7","key":"10.1016\/j.pmr.2018.03.004_bib54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/0883073817701526","article-title":"Serial casting as an adjunct to botulinum toxin type A treatment in children with cerebral palsy and spastic paraparesis with scissoring of the lower extremities","volume":"32","author":"Dai","year":"2017","journal-title":"J\u00a0Child Neurol"},{"issue":"18","key":"10.1016\/j.pmr.2018.03.004_bib55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/09638280110067180","article-title":"Serial plaster casting to correct equino-varus deformity of the ankle following acquired brain injury in adults","volume":"23","author":"Singer","year":"2001","journal-title":"Disabil Rehabil"},{"issue":"11","key":"10.1016\/j.pmr.2018.03.004_bib56","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/0269215507079141","article-title":"A\u00a0systematic review of upper extremity casting for children and adults with central nervous system motor disorders","volume":"21","author":"Lannin","year":"2007","journal-title":"Clin Rehabil"},{"issue":"7","key":"10.1016\/j.pmr.2018.03.004_bib57","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ptj\/83.7.648","article-title":"The use of casts in the managament of joint mobility and hypertonia following brain injury in adults: a systematic review","volume":"83","author":"Mortenson","year":"2003","journal-title":"Phys Ther"},{"key":"10.1016\/j.pmr.2018.03.004_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1191\/0269215503cr636oa","article-title":"The influence of illness duration and level of consciousness on the treatment effect and complication rate of serial casting in patients with severe cerebral palsy spasticity","volume":"17","author":"Pohl","year":"2003","journal-title":"Clin Rehabil"},{"issue":"4","key":"10.1016\/j.pmr.2018.03.004_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1310\/tsr1704-318","article-title":"The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke","volume":"14","author":"Karadag-Saygi","year":"2010","journal-title":"Top Stroke Rehabil"},{"issue":"1","key":"10.1016\/j.pmr.2018.03.004_bib60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0269215514537915","article-title":"Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial","volume":"29","author":"Santamato","year":"2015","journal-title":"Clin Rehabil"},{"issue":"7","key":"10.1016\/j.pmr.2018.03.004_bib61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/0269215512464502","article-title":"A\u00a0randomized controlled trial of surface neuromuscular electrical stimulation applied early after acute stroke: effects on wrist pain, spasticity and contractures","volume":"27","author":"Malhotra","year":"2012","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib62","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.apmr.2014.06.001","article-title":"Efficacy of addition of transcutaneous electrical nerve stimulation to standardized physical therapy in subacute spinal spasticity: a randomized controlled trial","volume":"95","author":"Oo","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"10.1016\/j.pmr.2018.03.004_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/088307380101600108","article-title":"Spasticity: orthopedic perspective","volume":"16","author":"Woo","year":"2001","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.pmr.2018.03.004_bib64","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jse.2012.10.043","article-title":"Myotendinous lengthening of the elbow flexor muscles to improve active motion in patients with elbow spasticity following brain injury","volume":"22","author":"Anakwenze","year":"2013","journal-title":"J\u00a0Shoulder Elbow Surg"},{"key":"10.1016\/j.pmr.2018.03.004_bib65","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00264-015-2793-8","article-title":"The split anterior tibialis tendon transfer procedure for spastic equinovarus foot in children with cerebral palsy: results and factors associated with a failed outcome","volume":"39","author":"Limpaphayom","year":"2015","journal-title":"Int Orthopaedics"},{"issue":"3","key":"10.1016\/j.pmr.2018.03.004_bib66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/BPO.0000000000000675","article-title":"What\u2019s new in the orthopaedic treatment of cerebral palsy","volume":"37","author":"Aversano","year":"2017","journal-title":"J\u00a0Pediatr Orthop"},{"key":"10.1016\/j.pmr.2018.03.004_bib67","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00701-013-1770-5","article-title":"Long-term neuromechanical results of selective tibial neurotomy in patients with spastic equinus foot","volume":"155","author":"Buffenoir","year":"2013","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.pmr.2018.03.004_bib68","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.apmr.2010.04.010","article-title":"Selective tibial neurotomy in the treatment of spastic equinovarus foot in hemiplegic patients: a 2-year longitudinal follow-up of 30 cases","volume":"91","author":"Deltombe","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rehab.2014.12.003","article-title":"Comparison between tibial nerve block with anaesthetics and neurotomy in hemiplegic adults with spastic equinovarus foot","volume":"58","author":"Deltombe","year":"2015","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1016\/j.pmr.2018.03.004_bib70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3171\/2013.4.PEDS12539","article-title":"Long-term functional benefits of selective dorsal rhizotomy for spastic cerebral palsy","volume":"12","author":"Dudley","year":"2013","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.004_bib71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1179\/2045772313Y.0000000149","article-title":"Modification of spasticity by transcutaneous spinal cord stimulation in individuals with incomplete spinal cord injury","volume":"37","author":"Hofstoetter","year":"2014","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.pmr.2018.03.004_bib72","first-page":"870398","article-title":"Acupuncture for spasticity after stroke: a systematic review and meta-analysis of randomized controlled trials","volume":"2015","author":"Lin","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.pmr.2018.03.004_bib73","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.apmr.2012.04.002","article-title":"Focal muscle vibration in the treatment of upper limb spasticity: a pilot randomized controlled trial in patients with chronic stroke","volume":"93","author":"Caliandro","year":"2012","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib74","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.pmrj.2016.03.004","article-title":"Effect of focal muscle vibration on calf muscle spasticity: a proof-of-concept study","volume":"8","author":"Seo","year":"2016","journal-title":"PM R"},{"key":"10.1016\/j.pmr.2018.03.004_bib75","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/PHM.0000000000000098","article-title":"Effects of vibration on spasticity in individuals with spinal cord injury: a scoping systematic review","volume":"93","author":"Sadeghi","year":"2014","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib76","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ctcp.2013.10.002","article-title":"Feasibility of using whole body vibration as a means for controlling spasticity in post-stroke patients: a pilot study","volume":"20","author":"Miyara","year":"2014","journal-title":"Complement Ther Clin Pract"},{"issue":"2","key":"10.1016\/j.pmr.2018.03.004_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ultrasmedbio.2012.09.019","article-title":"SBOTE study: extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type A injection for post-stroke spasticity-a prospective randomized trial","volume":"39","author":"Santamato","year":"2013","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"10.1016\/j.pmr.2018.03.004_bib78","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5535\/arm.2013.37.4.461","article-title":"The effect of extracorporeal shock wave therapy on lower limb spasticity in subacute stroke patients","volume":"37","author":"Moon","year":"2013","journal-title":"Ann Rehabil Med"},{"key":"10.1016\/j.pmr.2018.03.004_bib79","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.pmrj.2017.03.014","article-title":"Spasticity management: the current state of transcranial neuromodulation","volume":"9","author":"Leo","year":"2017","journal-title":"PM R"},{"issue":"7","key":"10.1016\/j.pmr.2018.03.004_bib80","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4103\/1673-5374.131574","article-title":"Outcomes in spasticity after repetitive transcranial magnetic and transcranial direct current stimulations","volume":"9","author":"Gunduz","year":"2014","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.pmr.2018.03.004_bib81","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.apmr.2013.10.023","article-title":"Efficacy of coupling repetitive transcranial magnetic stimulation and physical therapy to reduce upper-limb spasticity in patients with stroke: a randomized controlled trial","volume":"95","author":"Glavao","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apmr.2012.07.022","article-title":"Effects on decreasing upper-limb poststroke muscle tone using transcranial direct current stimulation: a randomized sham-controlled study","volume":"94","author":"Wu","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.pmr.2018.03.004_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2017-016843","article-title":"A\u00a0randomized controlled cross-over double-blind pilot study on THC: CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity","volume":"7","author":"Marinelli","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.pmr.2018.03.004_bib84","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-014-0197-5","article-title":"Delta-9-tetrahydrocannabinol\/cannabidiol (sativex): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis","volume":"74","author":"Syed","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.pmr.2018.03.004_bib85","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-017-0720-6","article-title":"Delta-9-tetrahydrocannabinol\/cannsbidiol oromucosal spray (sativex): a review in multiple sclerosi-related spasticity","volume":"77","author":"Keating","year":"2017","journal-title":"Drugs"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965118307629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965118307629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:41:11Z","timestamp":1760931671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965118307629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1047965118307629"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2018.03.004","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle Overactivity in the Upper Motor Neuron Syndrome","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}